Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics
EventHuman
- The original event time is:
- Tuesday, September 24, 2024 - 09:00 - 17:00 Amsterdam time (CEST)
Date
- , -
Location
- OnlineEuropean Medicines Agency, Amsterdam, the NetherlandsLive broadcast
Event summary
The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) are organising a multi-stakeholder hybrid workshop on Pharmacogenomics at EMA in Amsterdam.
The objectives of the workshop are to:
- identify priority areas for additional regulatory action to promote the clinical implementation of pharmacogenomics;
- discuss how medicines regulators can facilitate the uptake of genomics by national healthcare systems;
- discuss how to leverage genomic data linked to real-world data sources with examples of current studies using such data;
- discuss how to increase the regulatory impact of EU-funded projects in personalised medicine.
The outcome of the workshop will inform a roadmap towards the clinical implementation of pharmacogenomics in Europe.
Virtual participation to the event is open to all stakeholders. Prior registration will be required. In-person participation will be confirmed by invitation only.
The event will be broadcast and recorded, and the recording will be made available on the EMA event page a few weeks after the event.
Registration
Registration is closed